Exosome engineering for efficient and targeted drug delivery: Current status and future perspective

Abstract

Exosomes are membrane‐bound vesicles that are released by most cells. They carry nucleic acids, cytokines, growth factors, proteins, lipids, and metabolites. They are responsible for inter‐ and intracellular communications and their role in drug delivery is well defined. Exosomes have great potential for therapeutic applications, but the clinical use is restricted because of limitations in standardized procedures for isolation, purification, and drug delivery. Bioengineering of exosomes could be one approach to achieve standardization and reproducible isolation for clinical use. Exosomes are important transporters for targeted drug delivery because of their small size, stable structure, non‐immunogenicity, and non‐toxic nature, as well as their ability to carry a wide variety of compounds. These features of exosomes can be enhanced further by bioengineering. In this review, possible exosome bioengineering approaches, their biomedical applications, and targeted drug delivery are discussed. image

Different Sourced Extracellular Vesicles and Their Potential Applications in Clinical Treatments

“…Mesenchymal stem cells (MSCs) include multipotent stem cells which are capable of self-renewal and differentiation to a huge variety of cell lineages such as osteocytes, myocytes, adipocytes, chondrocytes, and neurocytes [89][90][91][92]. MSCs can be found in different parts of the body and their principal function is considered to be dead cell replacement through migration to damaged tissue and differentiation into the desired cell type which ultimately results in physiological homeostasis [93,94].…”

Mesenchymal Stem Cells and MSCs-Derived Extracellular Vesicles in Infectious Diseases: From Basic Research to Clinical Practice

“…It has been shown that a biocompatible self-assembling RGD hydrogel easily conjugates with EVs, and such constructs increase the therapeutic efficacy of MSC-derived vesicles for the treatment of kidneys [ 144 ], liver [ 145 ], and other organs [ 146 ]. Loading EVs with various drugs also enhances their therapeutic effect [ 147 , 148 , 149 ].…”

Exosomes: Biogenesis, targeting, characterization and their potential as "Plug & Play" vaccine platforms

“…Exosomes can present antigens to the immune system and trigger an immune response via a number of mechanisms as outlined in Figure 3. Indeed, the benefits of using exosomes as antigen‐carrying agents include their general low or non‐immunogenicity [ 34 ] ; however, changes to the constituent molecules within an exosome can inhibit or activate the immune response. [ 35 ] For example, the presence of the programmed and cell death ligand‐1 (PD‐L1) transmembrane protein in exosomes can result in tumor immune escape which leads to immunotherapy resistance arising.…”